nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—Doxorubicin—peripheral nervous system neoplasm	0.389	0.53	CbGbCtD
L-Carnitine—MPO—Cisplatin—peripheral nervous system neoplasm	0.1	0.136	CbGbCtD
L-Carnitine—XDH—Cisplatin—peripheral nervous system neoplasm	0.1	0.136	CbGbCtD
L-Carnitine—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0781	0.107	CbGbCtD
L-Carnitine—XDH—Doxorubicin—peripheral nervous system neoplasm	0.067	0.0913	CbGbCtD
L-Carnitine—XDH—Effects of Nitric Oxide—MB—peripheral nervous system neoplasm	0.0115	0.187	CbGpPWpGaD
L-Carnitine—CROT—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.0059	1	CbGdCrCtD
L-Carnitine—SLC25A29—ganglion—peripheral nervous system neoplasm	0.00567	0.224	CbGeAlD
L-Carnitine—CES1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00278	0.0452	CbGpPWpGaD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.00267	0.0435	CbGpPWpGaD
L-Carnitine—SLC25A20—trigeminal ganglion—peripheral nervous system neoplasm	0.00222	0.0879	CbGeAlD
L-Carnitine—CRAT—trigeminal ganglion—peripheral nervous system neoplasm	0.00216	0.0853	CbGeAlD
L-Carnitine—SLC25A20—parotid gland—peripheral nervous system neoplasm	0.0021	0.0829	CbGeAlD
L-Carnitine—CRAT—parotid gland—peripheral nervous system neoplasm	0.00203	0.0804	CbGeAlD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.00194	0.0315	CbGpPWpGaD
L-Carnitine—Choline—BCHE—peripheral nervous system neoplasm	0.00183	1	CrCbGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00177	0.0287	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.00172	0.028	CbGpPWpGaD
L-Carnitine—CPT2—trigeminal ganglion—peripheral nervous system neoplasm	0.00166	0.0656	CbGeAlD
L-Carnitine—CPT2—parotid gland—peripheral nervous system neoplasm	0.00156	0.0618	CbGeAlD
L-Carnitine—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.0014	0.0228	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00125	0.0204	CbGpPWpGaD
L-Carnitine—SLC25A29—cerebellum—peripheral nervous system neoplasm	0.00121	0.048	CbGeAlD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.00119	0.0194	CbGpPWpGaD
L-Carnitine—SLCO1B1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00119	0.0193	CbGpPWpGaD
L-Carnitine—CROT—cerebellum—peripheral nervous system neoplasm	0.00111	0.0441	CbGeAlD
L-Carnitine—XDH—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00107	0.0174	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00107	0.0173	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00107	0.0173	CbGpPWpGaD
L-Carnitine—SLC25A20—cerebellum—peripheral nervous system neoplasm	0.000969	0.0383	CbGeAlD
L-Carnitine—CRAT—cerebellum—peripheral nervous system neoplasm	0.00094	0.0372	CbGeAlD
L-Carnitine—CPT2—PPAR Alpha Pathway—MYC—peripheral nervous system neoplasm	0.000896	0.0146	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.000875	0.0142	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000826	0.0134	CbGpPWpGaD
L-Carnitine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000767	0.0125	CbGpPWpGaD
L-Carnitine—CPT1A—cerebellum—peripheral nervous system neoplasm	0.000762	0.0301	CbGeAlD
L-Carnitine—CPT2—cerebellum—peripheral nervous system neoplasm	0.000723	0.0286	CbGeAlD
L-Carnitine—SLC25A20—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000702	0.0114	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000702	0.0114	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000686	0.0112	CbGpPWpGaD
L-Carnitine—SLC22A8—trigeminal ganglion—peripheral nervous system neoplasm	0.000657	0.026	CbGeAlD
L-Carnitine—CPT1A—PPAR Alpha Pathway—MYC—peripheral nervous system neoplasm	0.000621	0.0101	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000574	0.00933	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000558	0.00907	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000551	0.00896	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000509	0.00827	CbGpPWpGaD
L-Carnitine—SLC22A5—trigeminal ganglion—peripheral nervous system neoplasm	0.000497	0.0197	CbGeAlD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000476	0.00774	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000474	0.00771	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000474	0.00771	CbGpPWpGaD
L-Carnitine—SLC22A5—parotid gland—peripheral nervous system neoplasm	0.000469	0.0185	CbGeAlD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000466	0.00758	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000464	0.00754	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000453	0.00736	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000407	0.00661	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GNS—peripheral nervous system neoplasm	0.000403	0.00656	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000394	0.00641	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000394	0.00641	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—NME1—peripheral nervous system neoplasm	0.000387	0.00629	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000381	0.00619	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00038	0.00617	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—COX2—peripheral nervous system neoplasm	0.000372	0.00605	CbGpPWpGaD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000344	0.00559	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GNS—peripheral nervous system neoplasm	0.000343	0.00558	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GNS—peripheral nervous system neoplasm	0.000343	0.00558	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000339	0.00551	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—NME1—peripheral nervous system neoplasm	0.000329	0.00535	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—NME1—peripheral nervous system neoplasm	0.000329	0.00535	CbGpPWpGaD
L-Carnitine—SLC22A4—cerebellum—peripheral nervous system neoplasm	0.000328	0.013	CbGeAlD
L-Carnitine—CES1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000327	0.00532	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—COX2—peripheral nervous system neoplasm	0.000317	0.00515	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—COX2—peripheral nervous system neoplasm	0.000317	0.00515	CbGpPWpGaD
L-Carnitine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000315	0.00183	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000314	0.0051	CbGpPWpGaD
L-Carnitine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000313	0.00182	CcSEcCtD
L-Carnitine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000312	0.00182	CcSEcCtD
L-Carnitine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000312	0.00181	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000312	0.00507	CbGpPWpGaD
L-Carnitine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000311	0.00181	CcSEcCtD
L-Carnitine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.00181	CcSEcCtD
L-Carnitine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000311	0.00181	CcSEcCtD
L-Carnitine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000311	0.00181	CcSEcCtD
L-Carnitine—Back pain—Etoposide—peripheral nervous system neoplasm	0.000308	0.00179	CcSEcCtD
L-Carnitine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000307	0.00179	CcSEcCtD
L-Carnitine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000307	0.00178	CcSEcCtD
L-Carnitine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000306	0.00178	CcSEcCtD
L-Carnitine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000306	0.00178	CcSEcCtD
L-Carnitine—CPT2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000306	0.00497	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000303	0.00176	CcSEcCtD
L-Carnitine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000303	0.00176	CcSEcCtD
L-Carnitine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000301	0.00175	CcSEcCtD
L-Carnitine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.00175	CcSEcCtD
L-Carnitine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000301	0.00175	CcSEcCtD
L-Carnitine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000301	0.00175	CcSEcCtD
L-Carnitine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.0003	0.00174	CcSEcCtD
L-Carnitine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00174	CcSEcCtD
L-Carnitine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.00173	CcSEcCtD
L-Carnitine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000297	0.00173	CcSEcCtD
L-Carnitine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000296	0.00172	CcSEcCtD
L-Carnitine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000295	0.00172	CcSEcCtD
L-Carnitine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000294	0.00171	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000294	0.00171	CcSEcCtD
L-Carnitine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.0017	CcSEcCtD
L-Carnitine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000293	0.0017	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000292	0.0017	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000292	0.00474	CbGpPWpGaD
L-Carnitine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000291	0.00169	CcSEcCtD
L-Carnitine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000291	0.00169	CcSEcCtD
L-Carnitine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00029	0.00169	CcSEcCtD
L-Carnitine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00168	CcSEcCtD
L-Carnitine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000288	0.00168	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.00167	CcSEcCtD
L-Carnitine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000286	0.00166	CcSEcCtD
L-Carnitine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.00166	CcSEcCtD
L-Carnitine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.00166	CcSEcCtD
L-Carnitine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000284	0.00165	CcSEcCtD
L-Carnitine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000284	0.00165	CcSEcCtD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.000283	0.0046	CbGpPWpGaD
L-Carnitine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00164	CcSEcCtD
L-Carnitine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000282	0.00164	CcSEcCtD
L-Carnitine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000279	0.00162	CcSEcCtD
L-Carnitine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000279	0.00162	CcSEcCtD
L-Carnitine—Rash—Topotecan—peripheral nervous system neoplasm	0.000279	0.00162	CcSEcCtD
L-Carnitine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000279	0.00162	CcSEcCtD
L-Carnitine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000279	0.00162	CcSEcCtD
L-Carnitine—Cough—Etoposide—peripheral nervous system neoplasm	0.000278	0.00162	CcSEcCtD
L-Carnitine—Headache—Topotecan—peripheral nervous system neoplasm	0.000278	0.00161	CcSEcCtD
L-Carnitine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000277	0.00161	CcSEcCtD
L-Carnitine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000277	0.00161	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000277	0.00161	CcSEcCtD
L-Carnitine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000277	0.00161	CcSEcCtD
L-Carnitine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000277	0.00161	CcSEcCtD
L-Carnitine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000277	0.00161	CcSEcCtD
L-Carnitine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000276	0.0016	CcSEcCtD
L-Carnitine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000276	0.0016	CcSEcCtD
L-Carnitine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000275	0.0016	CcSEcCtD
L-Carnitine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000275	0.0016	CcSEcCtD
L-Carnitine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000275	0.0016	CcSEcCtD
L-Carnitine—Pain—Vincristine—peripheral nervous system neoplasm	0.000274	0.0016	CcSEcCtD
L-Carnitine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000274	0.0016	CcSEcCtD
L-Carnitine—Rash—Melphalan—peripheral nervous system neoplasm	0.000274	0.00159	CcSEcCtD
L-Carnitine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000273	0.00159	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.00158	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000272	0.00442	CbGpPWpGaD
L-Carnitine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000271	0.00158	CcSEcCtD
L-Carnitine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00157	CcSEcCtD
L-Carnitine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000265	0.00154	CcSEcCtD
L-Carnitine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000265	0.00154	CcSEcCtD
L-Carnitine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000263	0.00153	CcSEcCtD
L-Carnitine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000263	0.00153	CcSEcCtD
L-Carnitine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000263	0.00153	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000262	0.00153	CcSEcCtD
L-Carnitine—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00153	CcSEcCtD
L-Carnitine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00152	CcSEcCtD
L-Carnitine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000261	0.00152	CcSEcCtD
L-Carnitine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000261	0.00152	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000259	0.0015	CcSEcCtD
L-Carnitine—Infection—Etoposide—peripheral nervous system neoplasm	0.000258	0.0015	CcSEcCtD
L-Carnitine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000258	0.0015	CcSEcCtD
L-Carnitine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000258	0.0015	CcSEcCtD
L-Carnitine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000256	0.00149	CcSEcCtD
L-Carnitine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000255	0.00148	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000254	0.00413	CbGpPWpGaD
L-Carnitine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000254	0.00148	CcSEcCtD
L-Carnitine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000254	0.00148	CcSEcCtD
L-Carnitine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000254	0.00148	CcSEcCtD
L-Carnitine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000253	0.00147	CcSEcCtD
L-Carnitine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000248	0.00144	CcSEcCtD
L-Carnitine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000247	0.00143	CcSEcCtD
L-Carnitine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000247	0.00143	CcSEcCtD
L-Carnitine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000246	0.00143	CcSEcCtD
L-Carnitine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.00143	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000245	0.00142	CcSEcCtD
L-Carnitine—CROT—Metabolism—ENO2—peripheral nervous system neoplasm	0.000244	0.00397	CbGpPWpGaD
L-Carnitine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000243	0.00141	CcSEcCtD
L-Carnitine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.00141	CcSEcCtD
L-Carnitine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000243	0.00141	CcSEcCtD
L-Carnitine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00141	CcSEcCtD
L-Carnitine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00139	CcSEcCtD
L-Carnitine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.00138	CcSEcCtD
L-Carnitine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000236	0.00137	CcSEcCtD
L-Carnitine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.00137	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000235	0.00381	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—TP53—peripheral nervous system neoplasm	0.000234	0.0038	CbGpPWpGaD
L-Carnitine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000233	0.00136	CcSEcCtD
L-Carnitine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00136	CcSEcCtD
L-Carnitine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00135	CcSEcCtD
L-Carnitine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000232	0.00135	CcSEcCtD
L-Carnitine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00023	0.00134	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00023	0.00374	CbGpPWpGaD
L-Carnitine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000228	0.00133	CcSEcCtD
L-Carnitine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.00133	CcSEcCtD
L-Carnitine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000228	0.00133	CcSEcCtD
L-Carnitine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000227	0.00132	CcSEcCtD
L-Carnitine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000226	0.00131	CcSEcCtD
L-Carnitine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000225	0.00131	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000224	0.00131	CcSEcCtD
L-Carnitine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000224	0.0013	CcSEcCtD
L-Carnitine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000222	0.00129	CcSEcCtD
L-Carnitine—Pain—Etoposide—peripheral nervous system neoplasm	0.000222	0.00129	CcSEcCtD
L-Carnitine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00129	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000222	0.0036	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GNS—peripheral nervous system neoplasm	0.000221	0.00359	CbGpPWpGaD
L-Carnitine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00022	0.00128	CcSEcCtD
L-Carnitine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00022	0.00128	CcSEcCtD
L-Carnitine—SLC22A5—cerebellum—peripheral nervous system neoplasm	0.000217	0.00857	CbGeAlD
L-Carnitine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00125	CcSEcCtD
L-Carnitine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.00125	CcSEcCtD
L-Carnitine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000214	0.00125	CcSEcCtD
L-Carnitine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000213	0.00124	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000213	0.00124	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000212	0.00345	CbGpPWpGaD
L-Carnitine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000212	0.00123	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000212	0.00344	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NME1—peripheral nervous system neoplasm	0.000212	0.00344	CbGpPWpGaD
L-Carnitine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.00123	CcSEcCtD
L-Carnitine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00122	CcSEcCtD
L-Carnitine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00122	CcSEcCtD
L-Carnitine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000209	0.00122	CcSEcCtD
L-Carnitine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000209	0.00121	CcSEcCtD
L-Carnitine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00121	CcSEcCtD
L-Carnitine—XDH—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000208	0.00338	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ENO2—peripheral nervous system neoplasm	0.000208	0.00338	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ENO2—peripheral nervous system neoplasm	0.000208	0.00338	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000206	0.00336	CbGpPWpGaD
L-Carnitine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000206	0.0012	CcSEcCtD
L-Carnitine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000206	0.0012	CcSEcCtD
L-Carnitine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000206	0.0012	CcSEcCtD
L-Carnitine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000206	0.0012	CcSEcCtD
L-Carnitine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.00119	CcSEcCtD
L-Carnitine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00119	CcSEcCtD
L-Carnitine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000204	0.00119	CcSEcCtD
L-Carnitine—CPT2—Metabolism—COX2—peripheral nervous system neoplasm	0.000204	0.00332	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000204	0.00331	CbGpPWpGaD
L-Carnitine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000204	0.00118	CcSEcCtD
L-Carnitine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000204	0.00118	CcSEcCtD
L-Carnitine—Rash—Vincristine—peripheral nervous system neoplasm	0.000202	0.00118	CcSEcCtD
L-Carnitine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000202	0.00118	CcSEcCtD
L-Carnitine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00117	CcSEcCtD
L-Carnitine—Headache—Vincristine—peripheral nervous system neoplasm	0.000201	0.00117	CcSEcCtD
L-Carnitine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.00115	CcSEcCtD
L-Carnitine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.00115	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000198	0.00322	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—AKT1—peripheral nervous system neoplasm	0.000197	0.00321	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000197	0.0032	CbGpPWpGaD
L-Carnitine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000194	0.00113	CcSEcCtD
L-Carnitine—CROT—Metabolism—TH—peripheral nervous system neoplasm	0.000194	0.00316	CbGpPWpGaD
L-Carnitine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000192	0.00111	CcSEcCtD
L-Carnitine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000192	0.00111	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00111	CcSEcCtD
L-Carnitine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000191	0.00111	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00111	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.0011	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.00019	0.00308	CbGpPWpGaD
L-Carnitine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.0011	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.00109	CcSEcCtD
L-Carnitine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000187	0.00108	CcSEcCtD
L-Carnitine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00108	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000184	0.00299	CbGpPWpGaD
L-Carnitine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000184	0.00107	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000183	0.00298	CbGpPWpGaD
L-Carnitine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00107	CcSEcCtD
L-Carnitine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00018	0.00105	CcSEcCtD
L-Carnitine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000179	0.00104	CcSEcCtD
L-Carnitine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000179	0.00104	CcSEcCtD
L-Carnitine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000178	0.00103	CcSEcCtD
L-Carnitine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.00103	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000176	0.00286	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000176	0.00285	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—BCHE—peripheral nervous system neoplasm	0.000176	0.00285	CbGpPWpGaD
L-Carnitine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000175	0.00102	CcSEcCtD
L-Carnitine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000173	0.001	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.001	CcSEcCtD
L-Carnitine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000172	0.001	CcSEcCtD
L-Carnitine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000998	CcSEcCtD
L-Carnitine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000986	CcSEcCtD
L-Carnitine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000169	0.00098	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000167	0.00272	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000167	0.00272	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000166	0.0027	CbGpPWpGaD
L-Carnitine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000165	0.000961	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—TH—peripheral nervous system neoplasm	0.000165	0.00268	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—TH—peripheral nervous system neoplasm	0.000165	0.00268	CbGpPWpGaD
L-Carnitine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00096	CcSEcCtD
L-Carnitine—Rash—Etoposide—peripheral nervous system neoplasm	0.000164	0.000953	CcSEcCtD
L-Carnitine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000164	0.000952	CcSEcCtD
L-Carnitine—Headache—Etoposide—peripheral nervous system neoplasm	0.000163	0.000947	CcSEcCtD
L-Carnitine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000941	CcSEcCtD
L-Carnitine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000933	CcSEcCtD
L-Carnitine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000929	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00016	0.00259	CbGpPWpGaD
L-Carnitine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000924	CcSEcCtD
L-Carnitine—CROT—Metabolism—GNAS—peripheral nervous system neoplasm	0.000158	0.00258	CbGpPWpGaD
L-Carnitine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000918	CcSEcCtD
L-Carnitine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000906	CcSEcCtD
L-Carnitine—CROT—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000156	0.00253	CbGpPWpGaD
L-Carnitine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000155	0.0009	CcSEcCtD
L-Carnitine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000154	0.000898	CcSEcCtD
L-Carnitine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000896	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000153	0.00249	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GNS—peripheral nervous system neoplasm	0.000153	0.00249	CbGpPWpGaD
L-Carnitine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000888	CcSEcCtD
L-Carnitine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000884	CcSEcCtD
L-Carnitine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000884	CcSEcCtD
L-Carnitine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000881	CcSEcCtD
L-Carnitine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000863	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—NME1—peripheral nervous system neoplasm	0.000147	0.00239	CbGpPWpGaD
L-Carnitine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000849	CcSEcCtD
L-Carnitine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000842	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000145	0.00235	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000144	0.00235	CbGpPWpGaD
L-Carnitine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000838	CcSEcCtD
L-Carnitine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000832	CcSEcCtD
L-Carnitine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000829	CcSEcCtD
L-Carnitine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000827	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—COX2—peripheral nervous system neoplasm	0.000141	0.0023	CbGpPWpGaD
L-Carnitine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000818	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000818	CcSEcCtD
L-Carnitine—XDH—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00014	0.00228	CbGpPWpGaD
L-Carnitine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000815	CcSEcCtD
L-Carnitine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000808	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000139	0.00225	CbGpPWpGaD
L-Carnitine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000792	CcSEcCtD
L-Carnitine—CRAT—Metabolism—GNAS—peripheral nervous system neoplasm	0.000135	0.00219	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GNAS—peripheral nervous system neoplasm	0.000135	0.00219	CbGpPWpGaD
L-Carnitine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000779	CcSEcCtD
L-Carnitine—CPT2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000134	0.00218	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000772	CcSEcCtD
L-Carnitine—CRAT—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000132	0.00215	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000132	0.00215	CbGpPWpGaD
L-Carnitine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000766	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000765	CcSEcCtD
L-Carnitine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000761	CcSEcCtD
L-Carnitine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000755	CcSEcCtD
L-Carnitine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000747	CcSEcCtD
L-Carnitine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000746	CcSEcCtD
L-Carnitine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000737	CcSEcCtD
L-Carnitine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000733	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000732	CcSEcCtD
L-Carnitine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000725	CcSEcCtD
L-Carnitine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000725	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000714	CcSEcCtD
L-Carnitine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000709	CcSEcCtD
L-Carnitine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000704	CcSEcCtD
L-Carnitine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000699	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000693	CcSEcCtD
L-Carnitine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00069	CcSEcCtD
L-Carnitine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000682	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000677	CcSEcCtD
L-Carnitine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00067	CcSEcCtD
L-Carnitine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00067	CcSEcCtD
L-Carnitine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00067	CcSEcCtD
L-Carnitine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00067	CcSEcCtD
L-Carnitine—CPT2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000113	0.00184	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000641	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00011	0.00178	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000109	0.00178	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000108	0.00175	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000108	0.00175	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000624	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00062	CcSEcCtD
L-Carnitine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00062	CcSEcCtD
L-Carnitine—CPT2—Metabolism—TH—peripheral nervous system neoplasm	0.000106	0.00173	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000105	0.00171	CbGpPWpGaD
L-Carnitine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000608	CcSEcCtD
L-Carnitine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000103	0.0006	CcSEcCtD
L-Carnitine—XDH—Metabolism—GNS—peripheral nervous system neoplasm	0.000101	0.00165	CbGpPWpGaD
L-Carnitine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.00058	CcSEcCtD
L-Carnitine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.94e-05	0.000578	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	9.93e-05	0.00161	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NME1—peripheral nervous system neoplasm	9.73e-05	0.00158	CbGpPWpGaD
L-Carnitine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.68e-05	0.000563	CcSEcCtD
L-Carnitine—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.00056	CcSEcCtD
L-Carnitine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000555	CcSEcCtD
L-Carnitine—XDH—Metabolism—COX2—peripheral nervous system neoplasm	9.36e-05	0.00152	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ENO2—peripheral nervous system neoplasm	9.28e-05	0.00151	CbGpPWpGaD
L-Carnitine—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.000539	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000536	CcSEcCtD
L-Carnitine—Rash—Epirubicin—peripheral nervous system neoplasm	9.19e-05	0.000534	CcSEcCtD
L-Carnitine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000534	CcSEcCtD
L-Carnitine—Headache—Epirubicin—peripheral nervous system neoplasm	9.13e-05	0.000531	CcSEcCtD
L-Carnitine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000518	CcSEcCtD
L-Carnitine—CPT2—Metabolism—GNAS—peripheral nervous system neoplasm	8.68e-05	0.00141	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.68e-05	0.00141	CbGpPWpGaD
L-Carnitine—Nausea—Epirubicin—peripheral nervous system neoplasm	8.66e-05	0.000503	CcSEcCtD
L-Carnitine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000499	CcSEcCtD
L-Carnitine—CPT2—Metabolism—ABCB1—peripheral nervous system neoplasm	8.52e-05	0.00139	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.52e-05	0.00138	CbGpPWpGaD
L-Carnitine—Rash—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000494	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000494	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000491	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.11e-05	0.00132	CbGpPWpGaD
L-Carnitine—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.01e-05	0.000466	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—BCHE—peripheral nervous system neoplasm	7.84e-05	0.00127	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.48e-05	0.00122	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.39e-05	0.0012	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TH—peripheral nervous system neoplasm	7.37e-05	0.0012	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.33e-05	0.00119	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.52e-05	0.00106	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.4e-05	0.00104	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ENO2—peripheral nervous system neoplasm	6.15e-05	0.001	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.14e-05	0.000998	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GNAS—peripheral nervous system neoplasm	6.02e-05	0.000979	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ABCB1—peripheral nervous system neoplasm	5.91e-05	0.00096	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.9e-05	0.000959	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.79e-05	0.000941	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.57e-05	0.000905	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	5.34e-05	0.000868	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—BCHE—peripheral nervous system neoplasm	5.19e-05	0.000845	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	5.12e-05	0.000832	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.96e-05	0.000806	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	4.93e-05	0.000801	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TH—peripheral nervous system neoplasm	4.88e-05	0.000794	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.48e-05	0.000728	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.4e-05	0.000715	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—peripheral nervous system neoplasm	4.28e-05	0.000696	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GNAS—peripheral nervous system neoplasm	3.99e-05	0.000648	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ABCB1—peripheral nervous system neoplasm	3.91e-05	0.000636	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—peripheral nervous system neoplasm	3.64e-05	0.000591	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—peripheral nervous system neoplasm	3.64e-05	0.000591	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	3.24e-05	0.000526	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	2.73e-05	0.000445	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.61e-05	0.000424	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	2.57e-05	0.000418	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—peripheral nervous system neoplasm	2.34e-05	0.000381	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	2.1e-05	0.000341	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.06e-05	0.000335	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000264	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—peripheral nervous system neoplasm	1.08e-05	0.000175	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	5.66e-06	9.21e-05	CbGpPWpGaD
